Sinéad M. Lougheed - Concepedia

Author

Sinéad M. Lougheed

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

S Lougheed, S.M. Lougheed, Sinead Lougheed, Sinead M. Lougheed, Sinéad Lougheed, Sinéad M Lougheed, Sinéad M. Lougheed, Sinéad Lougheed, Sinéad M Lougheed, Sinéad M. Lougheed

Publications

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Cancer Center Amsterdam Amsterdam University Medical Centers Radboud University Nijmegen

About

Sinéad M. Lougheed is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	934
2	Immunology	14	14	895
3	Cell Biology	13	13	816
4	Allergy	1	1	27
5	Microbiology	1	1	160

Sinéad M. Lougheed

Publications

Citations

H-Index

Page 1

	Year	Citations
Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation Claudia C. Sombroek, Anita G.M. Stam, Allan J. Masterson, The Journal of Immunology Dendritic CellImmunologyImmunoeditingDendritic Cell DifferentiationImmunotherapy	2002	202
Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression S. Rubina Baglio, Tonny Lagerweij, María Pérez-Lanzón, Clinical Cancer Research	2017	180
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+precursors Allan J. Masterson, Claudia C. Sombroek, Tanja D. de Gruijl, Blood	2002	162
Sensing of latent EBV infection through exosomal transfer of 5′pppRNA S. Rubina Baglio, Monique A.J. van Eijndhoven, Danijela Koppers‐Lalic, Proceedings of the National Academy of Sciences Microbial PathogensLatent Ebv InfectionViral PathogenesisImmunologyInnate Immunity	2016	160
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab Saskia J. Santegoets, Anita G.M. Stam, Sinéad M. Lougheed, Journal for ImmunoTherapy of Cancer	2014	103
Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation Rieneke van de Ven, Mari F.C.M. van den Hout, Jelle J. Lindenberg, Blood	2011	91
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment Saskia J. Santegoets, Anita G.M. Stam, Sinéad M. Lougheed, Cancer Immunology Immunotherapy Prostate Gvax/ipilimumab TreatmentUrologyCancer ImmunosurveillanceImmunologyAutoimmunity	2012	91
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells Renée C.G. de Bruin, John P. Veluchamy, Sinéad M. Lougheed, OncoImmunology	2017	82
A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor Saskia J. Santegoets, Allan J. Masterson, Pieter C van der Sluis, Journal of Leukocyte Biology Mutz-3 Cell LineDendritic CellLymphocyte DevelopmentMixed-phenotype Acute LeukemiaImmunology	2006	70
A Postmigrational Switch among Skin-Derived Dendritic Cells to a Macrophage-Like Phenotype Is Predetermined by the Intracutaneous Cytokine Balance Tanja D. de Gruijl, Claudia C. Sombroek, Sinéad M. Lougheed, The Journal of Immunology	2006	66

Page 1